Navigation Links
Oclaro(TM) Hits Milestone With Clarity(TM) Fluorescence Filters
Date:6/16/2009

SAN JOSE, Calif., June 17 /PRNewswire-FirstCall/ -- Oclaro, Inc. (Nasdaq: OCLR) has announced the shipment of its 200,000th Fluorescence Filter for biomedical and analytical instrumentation markets. Oclaro filters are used by leading companies in a wide range of biomedical and analytical applications, including clinical diagnostics, drug discovery, gene quantification, blood analysis, and disease detection. The latest offerings from the Oclaro filter portfolio are on display at LASER World of Photonics 2009 in Munich.

Oclaro Clarity(TM) Filters utilise proprietary AED (Advanced Energetic Deposition) coating technology to produce high performance band pass filters, dichroic mirrors, and laser beam combiners. The AED technology facilitates an environmentally stable hard coating that offers superb resistance, high transmission, and high out-of-band blocking. The state of the art Oclaro automated production facilities enable repeatability and high yield at large volumes, ensuring cost effective manufacturing and value for our customers.

"Oclaro Fluorescence Filters are based on proven telecom technology boasting zero failures in over 65 billion recorded hours of operation," said Yves LeMaitre, EVP and General Manager of the Oclaro Advanced Photonic Solutions (APS) division. "We have been manufacturing Clarity Fluorescence Filters for the biomedical market for over five years and have the expertise to deliver quality, innovative products to this demanding and dynamic market."

The APS division leverages the Oclaro telecom expertise and channels it into biomedical and industrial applications. The Clarity fluorescence filter is a prime example of bringing the best of telecom technology manufacturing into biomedical applications, which represents a strategic focus for the APS division of Oclaro.

The portfol
'/>"/>

SOURCE Oclaro, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
3. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Netsmart Technologies Customer in Pennsylvania Recognized for Achieving Data Benchmarking Milestones
6. SPO Medical Announces Major Sales Milestone
7. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
8. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
9. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
10. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
11. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... JourneyLite of Houston, LLC ann...ffer patients a second surgical option, vertical ...; System that it currently performs. The first sl...formed by surgeon partner, Matthew St. Laurent, M... doing well. ,, The Vertical Sleeve Gastrectomy...
(Date:12/3/2009)...Dec. 3 Peregrine Pharmac...at it will release its financial results for the s...2009 at 7:00 a.m. EST and will host a conference c...m. EST on the same day. ,, Peregrine,s senior m...econd quarter ended October 31, 2009 and will revi...
(Date:12/2/2009)...Dec. 2 Spectrum Blue Steel is emer...mpanies on the planet. Through the efforts of True...ent and Recycling Specialist Leroy Johnston, who h...s, stated that Spectrum Blue Steel is light years ...ctacular earnings because of the bi products recov...
(Date:12/2/2009)... The world,s first concept demonstr...breakthrough alternative to replace a petrochemica...hetic rubber with renewable biomass, made their de...ll be on display at a lounge in the common departu...roughout December 21, while the other tire will ma...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...1 NanoLogix, Inc. (Pink Sheets: NNLX) is pleased ...oard to help evaluate and target research and deve...ard provides the company with a vastly expanded sc...esearch. , , Dr. Robert Ollar, NanoLogix cofound...esigned from the NanoLogix Board of Directors to a...
...d LONDON, May 11 Nanosys Inc. and QuantuMDx Group ...exclusive license agreement with Nanosys for sever...use of nanowires for biosensors. , , The core i...based field effect transistors (FETs) as biosensor... Lieber, a professor of chemistry at Harvard , a ...
...rexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a...t of obesity, today announced that Jay Hagan has j... Corporate Development and Strategy. , , "Jay b... business development experience in a variety of r...of important transactions. We are excited to add ...
Other Biology Technology:A Global View: NanoLogix Creates Science Advisory Board 2A Global View: NanoLogix Creates Science Advisory Board 3A Global View: NanoLogix Creates Science Advisory Board 4A Global View: NanoLogix Creates Science Advisory Board 5Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies 2Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies 3Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 2Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 3Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 4
(Date:12/3/2009)... upset by a social snubbing? Your genetics, not yo...ong known that opium-like painkillers, called opio... forms of emotional stress. Now, a new study revie...g shows that small genetic differences in the gene...ty of people,s responses to social rejection. , ...
(Date:12/3/2009)...ntists from the U.S. Department of Energy,s (DOE) ..., and the Indian Institute of Science has made a m...e genetic information in DNA that is necessary to ...arch, published in the December 1, 2009 edition of... that many proteins responsible for interacting at...
(Date:12/2/2009)... results strengthen the evidence that people who s... increased risk for developing colorectal cancer, ..."This provides one more reason not to smoke, or to...hael J. Thun, M.D., M.S., vice president emeritus,...rican Cancer Society. "Colorectal cancer should be...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Peregrine Pharmaceuticals Awarded Second Broad U S Patent for Anti Viral Applications of Phospholipid Targeting Antibodies 5990 1Peregrine Pharmaceuticals Awarded Second Broad U S Patent for Anti Viral Applications of Phospholipid Targeting Antibodies 5990 2Peregrine Pharmaceuticals Awarded Second Broad U S Patent for Anti Viral Applications of Phospholipid Targeting Antibodies 5990 3Peregrine Pharmaceuticals Awarded Second Broad U S Patent for Anti Viral Applications of Phospholipid Targeting Antibodies 5990 4Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 1Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 2Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 3Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 4Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 5Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 6Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 7Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 8Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 9Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday November 10 2009 5986 1Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday November 10 2009 5986 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday November 10 2009 5986 3
...od Institute (NHLBI) of the National Institutes of...s in the United States for the diagnosis and manag...mmon inherited bleeding disorder. The guidelines i...sease management, and directions for future resear...ished online Feb. 29 in the journal Haemophilia. ...
... who can recognize and resist the persuasive tacti...to alcohol advertising and peer pressure to drink....y middle school students by Weill Cornell Medical ...Addictive Behaviors (April print edition). Previou...ising and adolescent alcohol, use as well as the i...
...eleased a report that identifies the potential vol...illion acres of Arizona forests, representing the ...ds over the issue of forest thinning. , The Wood ...ly of up to 850 million cubic feet of wood and 8 m...sidue for such commercial uses as pallets, firewoo...
Other Biology News:NHLBI issues first US von Willebrand Disease clinical practice guidelines 2NHLBI issues first US von Willebrand Disease clinical practice guidelines 3NHLBI issues first US von Willebrand Disease clinical practice guidelines 4Learning how to say 'no' to alcohol advertising and peer pressure works for inner-city adolescents 2Stakeholders use science to find common ground on wood supply from forests 2Stakeholders use science to find common ground on wood supply from forests 3
Universal Amplicon Detection Assay - Colorimetric from CHEMICON
Propidium Iodide Solution [3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide] from CHEMICON
...gents are complete ready-to-use reagents for the i...ifically formulated for the isolation of genomic D...y formulated for the isolation of genomic DNA from... can be used for restriction endonuclease digestio...
Propidium Iodide from GeneTex
Biology Products: